![Ilan Ganot](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Ilan Ganot
Oprichter bij
SOLID BIOSCIENCES INC.
Vermogen: 1 M $ op 30-09-2026
Profiel
Ilan Ganot is the founder of Solid Biosciences, Inc., founded in 2013, holding the title of Independent Director since 2022.
Mr. Ganot currently holds the position of Chief Executive Officer & Director at Alesta Therapeutics BV.
Education history includes an MBA from London Business School, conferred in 2003, and an undergraduate degree from The Interdisciplinary Center Herzliya, conferred in 1999.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 01-10-2026 | 146.165 ( 0,14% ) | 1 M $ | 30-09-2026 |
Actieve functies van Ilan Ganot
| Bedrijven | Functie | Begin |
|---|---|---|
| SOLID BIOSCIENCES INC. | Oprichter | 01-03-2013 |
Opleiding van Ilan Ganot
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
73
Eerstegraads connecties
3
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 3 |
|---|---|
London Business School
 London Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Interdisciplinary Center Herzliya
 The Interdisciplinary Center Herzliya Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Solid Biosciences, Inc.
 Solid Biosciences, Inc. BiotechnologyHealth Technology Operates as a pharmaceutical company that develops treatments through gene therapy for patients with duchenne disease | Health Technology |
